EUVIMEDEUVIMED entdecken
Open Access

Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6

Beate König, Paris R Watson, Nina Reßing, Abigail D Cragin iD, Linda Schäker-Hübner, David W Christianson iD, Finn K Hansen iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c01345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Beate König und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53121, Germany. Hauptthemen laut MEDLINE: Oxadiazoles, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Biological and Environmental Research, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone deacetylase 6 (HDAC6) is an important drug target in oncological and non-oncological diseases. Most available HDAC6 inhibitors (HDAC6i) utilize hydroxamic acids as a zinc-binding group, which limits therapeutic opportunities due to its genotoxic potential. Recently, difluoromethyl-1,3,4-oxadiazoles (DFMOs) were reported as potent and selective HDAC6i but their mode of inhibition remained enigmatic. Herein, we report that DFMOs act as mechanism-based and essentially irreversible HDAC6i. Biochemical data confirm that DFMO 6 is a tight-binding HDAC6i capable of inhibiting HDAC6 via a two-step slow-binding mechanism. Crystallographic and mechanistic experiments suggest that the attack of 6 by the zinc-bound water at the sp2 carbon closest to the difluoromethyl moiety followed by a subsequent ring opening of the oxadiazole yields deprotonated difluoroacetylhydrazide 13 as active species. The strong anionic zinc coordination of 13 and the binding of the difluoromethyl moiety in the P571 pocket finally result in an essentially irreversible inhibition of HDAC6.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxadiazolesHistone Deacetylase InhibitorsHistone Deacetylase 6ZincHydroxamic Acids

Substanzen

Histone Deacetylase 6OxadiazolesHistone Deacetylase InhibitorsZincHydroxamic Acids

Autor:innen und Institutionen

  • Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, Bonn 53121, Germany.
  • Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States.

ORCID-Profile: Abigail D Cragin, David W Christianson, Finn K Hansen

Förderung

  • NIGMS NIH HHS
  • Biological and Environmental Research
  • National Institute of General Medical Sciences
  • Bonn International Graduate School of Drug Sciences

Zitieren

APA

König, B., Watson, P. R., Reßing, N., Cragin, A. D., Schäker-Hübner, L., Christianson, D. W., & Hansen, F. K. (2023). Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01345

Vancouver

König B, Watson PR, Reßing N, Cragin AD, Schäker-Hübner L, Christianson DW, et al. Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01345

BibTeX
@article{Knig2023,
  author = {König, Beate and Watson, Paris R and Reßing, Nina and Cragin, Abigail D and Schäker-Hübner, Linda and Christianson, David W and Hansen, Finn K},
  title = {Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c01345}
}
Kostenlos starten →